Arndt Vogel: How to best manage Immune-Related Adverse Events?

Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared on X/Twitter:

“How to best manage Immune-Related Adverse Events? Impact of immunosuppressive agents on the management of irAEs of immune checkpoint blockers:

• Infliximab and Methotrexate: no impact on survival
• Steroids alone: worse outcome
• Better early use of immunosuppressants?”

Read further.
Source: Arndt Vogel/X

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”